Understanding the Risks of Investing in Kyverna Therapeutics Inc. (KYTX)

Kyverna Therapeutics Inc.’s recently made public that its 10% Owner GILEAD SCIENCES, INC. acquired Company’s shares for reported $20.02 million on Feb 12 ’24. In the deal valued at $22.00 per share,910,000 shares were bought. As a result of this transaction, GILEAD SCIENCES, INC. now holds 4,126,119 shares worth roughly $92.55 million. Then, Northpond Ventures […]

Kyverna Therapeutics Inc. [KYTX] Investment Appeal on the Rise

In a filing, Kyverna Therapeutics Inc. revealed its 10% Owner GILEAD SCIENCES, INC. acquired Company’s shares for reported $20.02 million on Feb 12 ’24. In the deal valued at $22.00 per share,910,000 shares were bought. As a result of this transaction, GILEAD SCIENCES, INC. now holds 4,126,119 shares worth roughly $92.92 million. Then, Northpond Ventures […]

Investing in Kyverna Therapeutics Inc. (KYTX): What You Must Know

Kyverna Therapeutics Inc.’s filing revealed that its 10% Owner GILEAD SCIENCES, INC. acquired Company’s shares for reported $20.02 million on Feb 12 ’24. In the deal valued at $22.00 per share,910,000 shares were bought. As a result of this transaction, GILEAD SCIENCES, INC. now holds 4,126,119 shares worth roughly $102.58 million. Then, Northpond Ventures III […]